Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Rhein

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Haematologica|August 6, 2013
High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocolGunnar Cario, Peter Rhein, Rita Mitlöhner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2011
Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemiaJana Hof, Stefanie Krentz, Claudia van Schewick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemiaRenate Kirschner-Schwabe, Claudio Lottaz, Jörn Tödling, et al.
Nature Immunology|January 2, 2026
Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to jointsMaria G Raimondo, Hashem Mohammadian, Mario R Angeli, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Haematologica|August 6, 2013
High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocolGunnar Cario, Peter Rhein, Rita Mitlöhner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2011
Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemiaJana Hof, Stefanie Krentz, Claudia van Schewick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemiaRenate Kirschner-Schwabe, Claudio Lottaz, Jörn Tödling, et al.
Nature Immunology|January 2, 2026
Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to jointsMaria G Raimondo, Hashem Mohammadian, Mario R Angeli, et al.
Pageof 2